Because carriers of FH variants remain underdiagnosed and undertreated in contemporary practice, identifying and targeting those carriers with interventions to enhance adherence to a healthy lifestyle may provide an opportunity to reduce their risk of CAD. The gene discussed is FH; the disease is coronary artery disorder.